We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEMB icon
2326
iShares JPMorgan EM Corporate Bond ETF
CEMB
$405M
$8.75M ﹤0.01%
197,580
+5,234
+3% +$231K
DWAS icon
2327
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$450M
$8.74M ﹤0.01%
102,769
+24,918
+32% +$2.15M
RCKT icon
2328
Rocket Pharmaceuticals
RCKT
$394M
$8.74M ﹤0.01%
405,782
-103,172
-20% -$2.37M
HLT icon
2329
PUT
Hilton Worldwide
HLT
$71.5B
$8.73M ﹤0.01%
40,000
-7,900
-16% -$1.62M
LBTYA icon
2330
PUT
Liberty Global Class A
LBTYA
$3.6B
$8.71M ﹤0.01%
+500,000
New +$8.46M
IYY icon
2331
iShares Dow Jones US ETF
IYY
$3.06B
$8.7M ﹤0.01%
65,769
-306
-0.5% -$39K
SU icon
2332
PUT
Suncor Energy
SU
$70.3B
$8.69M ﹤0.01%
228,200
NUMV icon
2333
Nuveen ESG Mid-Cap Value ETF
NUMV
$458M
$8.69M ﹤0.01%
262,988
-24,731
-9% -$820K
AFL icon
2334
PUT
Aflac
AFL
$62.6B
$8.67M ﹤0.01%
97,100
-9,300
-9% -$800K
AMT icon
2335
PUT
American Tower
AMT
$80.4B
$8.67M ﹤0.01%
44,600
-19,900
-31% -$3.72M
CGNX icon
2336
Cognex
CGNX
$11.3B
$8.66M ﹤0.01%
185,181
-5,424
-3% -$238K
TRU icon
2337
TransUnion
TRU
$15.3B
$8.66M ﹤0.01%
116,743
-36,417
-24% -$2.72M
OILK icon
2338
ProShares K-1 Free Crude Oil Strategy ETF
OILK
$190M
$8.66M ﹤0.01%
179,093
-9,202
-5% -$436K
OGN icon
2339
Organon & Co
OGN
$3.57B
$8.65M ﹤0.01%
418,036
-212,415
-34% -$4.22M
WDC icon
2340
CALL
Western Digital
WDC
$150B
$8.65M ﹤0.01%
151,087
-119,599
-44% -$6.63M
FINS
2341
Angel Oak Financial Strategies Income Term Trust
FINS
$421M
$8.64M ﹤0.01%
698,852
-17,323
-2% -$215K
COLB icon
2342
Columbia Banking Systems
COLB
$8.84B
$8.64M ﹤0.01%
434,485
+322,050
+286% +$6.12M
DG icon
2343
PUT
Dollar General
DG
$27.9B
$8.63M ﹤0.01%
65,300
-151,400
-70% -$21.1M
DYN icon
2344
Dyne Therapeutics
DYN
$4.9B
$8.61M ﹤0.01%
243,929
+10,602
+5% +$308K
BANC icon
2345
Banc of California
BANC
$2.97B
$8.61M ﹤0.01%
673,545
+584,039
+653% +$8.07M
HUN icon
2346
Huntsman Corp
HUN
$1.77B
$8.6M ﹤0.01%
377,555
+216,352
+134% +$5.27M
NUMG icon
2347
Nuveen ESG Mid-Cap Growth ETF
NUMG
$367M
$8.59M ﹤0.01%
205,542
-33,111
-14% -$1.4M
INSM icon
2348
PUT
Insmed
INSM
$28.6B
$8.59M ﹤0.01%
+128,200
New +$4.97M
CALY
2349
Callaway Golf Company
CALY
$3.14B
$8.58M ﹤0.01%
560,989
+307,150
+121% +$4.8M
CUBE icon
2350
CubeSmart
CUBE
$9.41B
$8.58M ﹤0.01%
189,993
-35,927
-16% -$1.55M

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.